ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury

计划入组 60 人 · 首次发布于 2025 年 8 月 29 日

Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease

计划入组 6 人 · 首次发布于 2024 年 3 月 6 日

ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

计划入组 12 人 · 首次发布于 2025 年 11 月 19 日

ARC-520

ARC-101

ARC-5690

Onward Medical Inc.

United States

ARC Funds Ltd

United States

ARC Medical Devices Inc

Canada

ONWARD Medical Secures $2.5M in Grants to Explore ARC-IM System for Parkinson's Disease Symptoms

ONWARD Medical Initiates Pivotal Study for Blood Pressure Control After Spinal Cord Injury

Onward Medical Secures $54M to Advance Neuromodulation Therapies for Spinal Cord Injury